Literature DB >> 4593555

A randomized controlled trial of acetyl salicylic acid in the secondary prevention of mortality from myocardial infarction.

P C Elwood, A L Cochrane, M L Burr, P M Sweetnam, G Williams, E Welsby, S J Hughes, R Renton.   

Abstract

The results of a randomized controlled trial of a single daily dose of acetyl salicylic acid (aspirin) in the prevention of reinfarction in 1,239 men who had had a recent myocardial infarct were statistically inconclusive. Nevertheless, they showed a reduction in total mortality of 12% at six months and 25% at twelve months after admission to the trial. Further trials are urgently required to establish whether or not this effect is real.

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4593555      PMCID： PMC1633246          DOI： 10.1136/bmj.1.5905.436

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  6 in total

1.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

2.  Maximum utilization of the life table method in analyzing survival.

Authors:  S J CUTLER; F EDERER
Journal:  J Chronic Dis       Date:  1958-12

3.  Salicylates, platelets and adenine nucleotides.

Authors:  D T Davies; A Hughes; R S Tonks
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1968

4.  Impaired platelet-connective-tissue reaction in man after aspirin ingestion.

Authors:  H J Weiss; L M Aledort
Journal:  Lancet       Date:  1967-09-02       Impact factor: 79.321

5.  Effects of salicylates on human platelets.

Authors:  J R O'Brien
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

6.  The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infarction.

Authors:  J R O'Brien; J B Heywood; J A Heady
Journal:  Thromb Diath Haemorrh       Date:  1966-12-01
  6 in total
  78 in total

1.  Platelet aggregation and incident ischaemic heart disease in the Caerphilly cohort.

Authors:  P C Elwood; S Renaud; A D Beswick; J R O'Brien; P M Sweetnam
Journal:  Heart       Date:  1998-12       Impact factor: 5.994

Review 2.  Aspirin in patients with coronary artery disease: is it simply irresistible?

Authors:  G V Nair; C J Davis; M E McKenzie; D R Lowry; V L Serebruany
Journal:  J Thromb Thrombolysis       Date:  2001-04       Impact factor: 2.300

3.  Sensitivity of fatty acid cyclooxygenase from human aorta to acetylation by aspirin.

Authors:  J W Burch; N L Baenziger; N Stanford; P W Majerus
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Prophylactic agents for thrombosis.

Authors:  P A Castaldi
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 5.  [Review of plasma anti-aggregants and their indications in primary care. Eight years later].

Authors:  M Blasco Valle; J F Lucía Cuesta
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

Review 6.  Beyond the mega-trial: certainty and uncertainty.

Authors:  J R Hampton; A M Skene
Journal:  Br Heart J       Date:  1992-10

7.  The "top 50": a perspective on the BMJ drawn from the Science Citation Index.

Authors:  B Dixon
Journal:  BMJ       Date:  1990-10-03

8.  Effects of various doses of aspirin on platelet activity and endothelial function.

Authors:  Takashi Furuno; Fumiyasu Yamasaki; Takeshi Yokoyama; Kyoko Sato; Takayuki Sato; Yoshinori Doi; Tetsuro Sugiura
Journal:  Heart Vessels       Date:  2010-11-10       Impact factor: 2.037

9.  Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-08

10.  Aspirin use and chronic diseases: a cohort study of the elderly.

Authors:  A Paganini-Hill; A Chao; R K Ross; B E Henderson
Journal:  BMJ       Date:  1989-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.